perillyl alcohol has been researched along with Local Neoplasm Recurrence in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Amorim, MR; D'Alincourt Salazar, M; da Fonseca, CO; Faria, GM; Pessoa, BL; Quirico-Santos, T; Soares, IDP | 1 |
Arnobio, A; Da Fonseca, CO; Futuro, D; Lins, IR; Quirico-Santos, T; Silva, JT; Simão, M | 1 |
Caetano, RO; da Fonseca, CO; Futuro, D; Lins, IR; Quirico-Santos, T; Simão, M | 1 |
da Fonseca, CO; Fischer, J; Futuro, D; Gattass, CR; Nagel, J; Quirico-Santos, T; Schwartsmann, G | 1 |
O'Shaughnessy, JA | 1 |
2 trial(s) available for perillyl alcohol and Local Neoplasm Recurrence
Article | Year |
---|---|
Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; DNA Methylation; Female; Glioblastoma; Humans; Leukocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Young Adult | 2020 |
Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
Topics: Administration, Intranasal; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Administration Schedule; Enzyme Inhibitors; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Monoterpenes; Neoplasm Recurrence, Local; Oncogene Protein p21(ras); Signal Transduction; Survival Rate; Temozolomide; Transforming Growth Factor beta; Treatment Outcome | 2008 |
3 other study(ies) available for perillyl alcohol and Local Neoplasm Recurrence
Article | Year |
---|---|
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.
Topics: Administration, Intranasal; Adult; Aged; Antineoplastic Agents; Brain Edema; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Treatment Outcome | 2009 |
Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
Topics: Administration, Intranasal; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Patient Selection | 2011 |
Chemoprevention of breast cancer.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Cyclohexenes; Dehydroepiandrosterone; Estrogen Antagonists; Female; Genistein; Humans; Isoflavones; Limonene; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Retinoids; Tamoxifen; Terpenes | 1996 |